News & Events Year None20202019201820172016201520142013201220112009 08/04/20 REGENXBIO Announces Additional Positive Interim Phase I/IIa Trial Update and Program Updates for RGX-314 for the Treatment of Wet AMD 07/30/20 REGENXBIO To Host Conference Call on August 6 to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights 07/08/20 REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic Neurodegenerative Diseases 06/10/20 REGENXBIO to Present at the Raymond James Human Health Innovation Conference 05/07/20 REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights 04/30/20 REGENXBIO To Host Conference Call on May 7 to Discuss First Quarter 2020 Financial Results and Recent Operational Highlights 04/28/20 REGENXBIO Announces Presentations at the American Society of Gene and Cell Therapy's 23rd Annual Meeting Pagination Current page 1 Page 2 Next page next › Last page last »
